Official release · Regulator bulletin
Medical Cannabis Certification – Preproposal Statement of Inquiry (CR 101) Filed
On October 9, 2026, the Liquor and Cannabis Board (LCB) took the following action:
Articles
Articles
200 articles
What’s changing in cannabis law: our editors’ articles, and announcements straight from regulators, courts, governments and companies.
66 articles
Press release · Canada Newswire
Canadians Decibel Cannabis Signs UK Licensing Deal with Hilltop Leaf
Decibel Cannabis Company Inc. has entered into a brand licensing agreement with Hilltop Leaf Ltd. to launch its cannabis flower portfolio in the United Kingdom’s medical market.
Press release · beardbrospharms.com
Beard Bros and British Cannabis Announce Commercial Collaboration With International Reach
Beard Bros and BRITISH CANNABIS™ have announced a commercial collaboration focused on developing and expanding cannabinoid products across the United Kingdom, Europe and North America.
Press release · PR Newswire
Curaleaf launch their “education” platform in Poland
Curaleaf International has announced the launch of the Curaleaf Education Platform in Poland, giving healthcare professionals across the country free access to structured, clinical training in medical cannabis.
Press release · GlobeNewswire
Clearmind Advances Dialogue with U.S. Federal Government on Psychedelic Therapies, Submitting Recommendations to FDA
Company Calls for Consideration of New Regulatory Pathways and Cost Saving of Non-Hallucinogenic Neuroplastogens for Alcohol Use Disorder
Press release · GlobeNewswire
MAPS and International Alliance of Psychedelic Therapy Practitioners Announce Partnership to Advance Training for Psychedelic-Assisted Therapy
Collaboration will increase access to practitioner education in the United States and internationally
Official release · Regulator bulletin
Alert: The Division of Cannabis Regulation (DCR) is aware of some confusion about testing requirements for ingestible marijuana concentrates.
The Division of Cannabis Regulation (DCR) is aware of some confusion about testing requirements for ingestible marijuana concentrates. Marijuana products such as Rick Simpson Oil (RSO) and Full Extract Cannabis Oil (FECO) are…
Press release · Cannabis Law Report
The Cannabis Regulatory Agency Announces Changes to Michigan Medical Marijuana Program Registry Cards
September 30, 2026 – The Cannabis Regulatory Agency will be implementing changes to the Michigan Medical Marijuana Program (MMMP) patient and caregiver registry cards on October 1st. The new registry cards will:
Press release · PR Newswire
Make War & Buds It’s Easy If You Know How: Israel’s IM cannabis publish another press release that says nothing about drones but actually its all about military drones
I think of it like this video except when you finally open it the gift is a lovely military drone that can kill all these kids.
Official release · Regulator bulletin
CRA Revokes 20 Medical Marijuana Grower Licenses, Issues $2 Million Fine Against Clare-Based GP Holdings LLC, DBA Millie Montana Industries
September 29, 2026 – The Cannabis Regulatory Agency (CRA) has revoked 20 medical marijuana Class C grower licenses held by GP Holdings LLC, doing business as Millie Montana Industries, and imposed a $2 million fine following…
Official release · health.mo.gov
Missouri House Bill 2641 Guidance ” some adjustment for cannabis facilities licensed under Article XIV. While not all of these changes fall under DCR’s regulatory authority, there are some new requirements DCR would like to highlight as licensees prepare for implementation. “
As you know, several changes in law are occurring or are scheduled to occur in the coming months that will require some adjustment for cannabis facilities licensed under Article XIV.
Official release · Court opinion
RN Collins (Series 3) No.7 – Federal Regulatory Standards After the MDMA Rejection: What FDA’s Complete Response Letter May Mean for the Psychedelic Pipeline
RN Collins has written a new series (3) of 18 articles for cannabis law report on 2026 Psychedelics & Legal Issues.
Official release · Regulator bulletin
Official Statement “Oregon Health Authority (OHA) will not be moving forward with the current psilocybin rulemaking process that would have included increased license fees.”
Oregon Health Authority (OHA) will not be moving forward with the current psilocybin rulemaking process that would have included increased license fees.
Press release · PR Newswire
Israeli Medical Cannabis Company IM Cannabis Signs Deal to Acquire 51% of “Tactical” Drone Company
Yep ,the nexus of the middle east Cannabis, weaponry and mioney, same as it always was.
Press release · EIN Presswire
SOMAÍ Brings Iridescent Med — One of Thailand’s Leading Medical Cannabis Brands —to the UK
Female-founded, indoor-grown flower brand enters Europe as SOMAÍ expands its international portfolio of pharmaceutical-grade cannabis medicines
Official release · maine.gov
Notice of Major Substantive Rulemaking -“For the Medical Cannabis Research Grant Program”
Today, in accordance with the Maine Administrative Procedure Act (MAPA) and 22 M.R.S. § 2430, the Office of Cannabis Policy (OCP) is formally engaging in major substantive rulemaking for the Medical Cannabis Research Grant…
Official release · Regulator bulletin
Alert: The September 2026 Public Comment Period for Oregon Psilocybin Services proposed rules will close on Monday, September 21st 2026 at 5:00pm
The September 2026 Public Comment Period for Oregon Psilocybin Services proposed rules will close on Monday, September 21st 2026 at 5:00pm (Pacific Time).
Official release · transport.nsw.gov.au
The Minns Labor Government’s legislation to create a more commonsense system for drivers who use lawfully prescribed medicinal cannabis has passed the NSW Parliament.
The Minns Labor Government’s legislation to create a more commonsense system for drivers who use lawfully prescribed medicinal cannabis has passed the NSW Parliament.
Press release · fidelity.com
Clearmind Medicine Delivers Briefing to FDA Following Invitation to Historic Psychedelic Hearing in Washington, D.C.
Mary-Elizabeth Gifford, Chief of Global Impact at Clearmind Medicine ( CMND ), spoke on patient access and shared insights from Clearmind’s clinical trial at Yale and Johns Hopkins
Press release · Cannabis Law Report
Cannabis Control Commission Kicks Off Major Regulatory Overhaul
WORCESTER—The Massachusetts Cannabis Control Commission on Sept. 17 will begin a series of public meetings to undertake one of the largest efforts to modernize cannabis regulations in Commission history, with topics including…
20 of 66